Novel Insights into MiR-944 in Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Sep 9

PMID 36077769

Authors

Jinze Shen

Qurui Wang

Chenhao Liang

Xinming Su

Yufei Ke

Yunan Mao

Jie Fang

Shiwei Duan

Affiliations

Soon will be listed here.

Abstract

miRNA is a class of endogenous short-chain non-coding RNAs consisting of about 22 nucleotides. miR-944 is located in the fourth intron of the TP63 gene in the 3q28 region. miR-944 is abnormally expressed in cancers in multiple systems including neural, endocrine, respiratory, reproductive, and digestive systems. miR-944 can target at least 27 protein-coding genes. miR-944 can regulate a series of cell behaviors, such as cell cycle, proliferation, invasion and migration, EMT, apoptosis, etc. miR-944 participates in the networks of 11 ceRNAs, including six circRNAs and five lncRNAs. miR-944 is involved in three signaling pathways. The abnormal expression of miR-944 is closely related to the clinicopathological conditions of various cancer patients. Deregulated expression of miR-944 is significantly associated with clinicopathology and prognosis in cancer patients. In addition, miR-944 is also associated with the development of DDP, RAPA, DOX, and PTX resistance in cancer cells. miR-944 is involved in the anticancer molecular mechanisms of matrine and Rhenium-liposome drugs. In conclusion, this work systematically summarizes the related findings of miR-944, which will provide potential hints for follow-up research on miR-944.

Citing Articles

Novel miRNA markers and their mechanism of esophageal squamous cell carcinoma (ESCC) based on TCGA.

Yuan P, Gao X, Xu M, Qiu L, Xiong Z, Shen J Sci Rep. 2024; 14(1):27261.

PMID: 39516222 PMC: 11549395. DOI: 10.1038/s41598-024-76321-0.

A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinoma.

Javanmardifard Z, Rahmani S, Bayat H, Mirtavoos-Mahyari H, Ghanei M, Mowla S Front Genet. 2024; 15:1419099.

PMID: 39381140 PMC: 11460580. DOI: 10.3389/fgene.2024.1419099.

Identification and Validation of IFI44 as a Novel Biomarker for Primary Sjögren's Syndrome.

Wei B, Yue Q, Ka Y, Sun C, Zhao Y, Ning X J Inflamm Res. 2024; 17:5723-5740.

PMID: 39219820 PMC: 11366250. DOI: 10.2147/JIR.S477490.

CLLU1 as an emerging biomarker in chronic lymphoid leukemia.

Rong C, Liang C, Shen J, Zhang Y, Wang Q, Yang F Hum Cell. 2024; 37(3):625-632.

PMID: 38507118 DOI: 10.1007/s13577-024-01051-4.

Construction and optimization of multi-platform precision pathways for precision medicine.

Tran A, Wang A, Mickaill J, Strbenac D, Larance M, Vernon S Sci Rep. 2024; 14(1):4248.

PMID: 38378802 PMC: 10879206. DOI: 10.1038/s41598-024-54517-8.

References

Tang J, Gao W, Liu G, Sheng W, Zhou J, Dong Q . miR-944 Suppresses EGF-Induced EMT in Colorectal Cancer Cells by Directly Targeting GATA6. Onco Targets Ther. 2021; 14:2311-2325. PMC: 8020141. DOI: 10.2147/OTT.S290567. View

Zhang L, Wu Y, Hou C, Li F . Circ_0072088 knockdown contributes to cisplatin sensitivity and inhibits tumor progression by miR-944/LASP1 axis in non-small cell lung cancer. J Gene Med. 2022; 24(5):e3414. DOI: 10.1002/jgm.3414. View

Johnson D, OKeefe R, Grandis J . Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018; 15(4):234-248. PMC: 5858971. DOI: 10.1038/nrclinonc.2018.8. View

Palatnik A, Ye S, Kendziorski C, Iden M, Zigman J, Hessner M . Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer. PLoS One. 2017; 12(8):e0181242. PMC: 5576712. DOI: 10.1371/journal.pone.0181242. View

Ji J, Peng Y, Niu T, Lin Y, Lin Y, Li X . miR-944 inhibits cell migration and invasion by targeting MACC1 in nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2020; 11(3):1167-1174. PMC: 6958143. View

Long X, Zheng M, Yang Y, Chen Y, Zhang X, Zhang H . circ_ZFR Is Linked to Paclitaxel Resistance in Cervical Cancer via miR-944 Sponging and IL-10 Upregulation. Anal Cell Pathol (Amst). 2022; 2022:4807287. PMC: 8813297. DOI: 10.1155/2022/4807287. View

Lv J, Li Q, Ma R, Wang Z, Yu Y, Liu H . Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis. Technol Cancer Res Treat. 2021; 20:1533033821990090. PMC: 7887693. DOI: 10.1177/1533033821990090. View

Chen L, Yang L . Regulation of circRNA biogenesis. RNA Biol. 2015; 12(4):381-8. PMC: 4615371. DOI: 10.1080/15476286.2015.1020271. View

Liu R, Zhou M, Zhang P, Zhao Y, Zhang Y . Cell proliferation and invasion is promoted by circSERPINA3 in nasopharyngeal carcinoma by regulating miR-944/MDM2 axis. J Cancer. 2020; 11(13):3910-3918. PMC: 7171482. DOI: 10.7150/jca.42799. View

10.

Zou T, Lin Z . The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression. Int J Mol Sci. 2021; 22(11). PMC: 8198665. DOI: 10.3390/ijms22115754. View

11.

Lin B, Wan S, Lin M, Chang C, Chen T, Yang M . Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor. Molecules. 2020; 25(16). PMC: 7463599. DOI: 10.3390/molecules25163609. View

12.

Peng H, Hsiao J, Chou S, Hsu Y, Wu G, Shieh Y . MiR-944/CISH mediated inflammation via STAT3 is involved in oral cancer malignance by cigarette smoking. Neoplasia. 2020; 22(11):554-565. PMC: 7505767. DOI: 10.1016/j.neo.2020.08.005. View

13.

Bagheri A, Nezafat N, Eslami M, Ghasemi Y, Negahdaripour M . Designing a therapeutic and prophylactic candidate vaccine against human papillomavirus through vaccinomics approaches. Infect Genet Evol. 2021; 95:105084. DOI: 10.1016/j.meegid.2021.105084. View

14.

Pan T, Chen W, Yuan X, Shen J, Qin C, Wang L . miR-944 inhibits metastasis of gastric cancer by preventing the epithelial-mesenchymal transition via MACC1/Met/AKT signaling. FEBS Open Bio. 2017; 7(7):905-914. PMC: 5494292. DOI: 10.1002/2211-5463.12215. View

15.

Yao Y, Chen S, Lu N, Yin Y, Liu Z . LncRNA JPX overexpressed in oral squamous cell carcinoma drives malignancy via miR-944/CDH2 axis. Oral Dis. 2020; 27(4):924-933. DOI: 10.1111/odi.13626. View

16.

Song W, Chen Y, Zhu G, Xie H, Yang Z, Li L . Exosome-mediated miR-9-5p promotes proliferation and migration of renal cancer cells both in vitro and in vivo by targeting SOCS4. Biochem Biophys Res Commun. 2020; 529(4):1216-1224. DOI: 10.1016/j.bbrc.2020.06.114. View

17.

Warnecke-Eberz U, Chon S, Holscher A, Drebber U, Bollschweiler E . Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Tumour Biol. 2015; 36(6):4643-53. DOI: 10.1007/s13277-015-3112-0. View

18.

Liu M, Zhou K, Cao Y . MicroRNA-944 Affects Cell Growth by Targeting EPHA7 in Non-Small Cell Lung Cancer. Int J Mol Sci. 2016; 17(10). PMC: 5085614. DOI: 10.3390/ijms17101493. View

19.

Arriola Apelo S, Lamming D . Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. J Gerontol A Biol Sci Med Sci. 2016; 71(7):841-9. PMC: 4906330. DOI: 10.1093/gerona/glw090. View

20.

Pastushenko I, Blanpain C . EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2018; 29(3):212-226. DOI: 10.1016/j.tcb.2018.12.001. View